Nectar Lifesciences announces Rs 81 crore share buyback at Rs 27 per share

Corporate Actions View source PDF Explain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹20.09

prior close

₹19.09

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-4.2% vs market

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-5.0-0.8-4.2

Next day

-7.0-0.8-6.2

-3.4+0.6-3.9

+1.4+0.8+0.7

-0.5+1.7-2.2

-4.8+2.0-6.8

-4.7+1.3-6.0

15d

-30.3-7.1-23.2

-31.4-6.8-24.6

-42.1-7.1-35.0

-53.7-15.7-38.0

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nectar Lifesciences to buy back up to 3 crore shares at Rs 27 each, totaling Rs 81 crore, via tender offer on a proportionate basis. This equals 13.38 percent of paid-up equity capital. Record date is December 24, 2025. Buyback opens December 31, 2025 and closes January 6, 2026. Entitlement ratio is 25 shares per 103 held. Promoters are not participating. Funded from securities premium and free reserves.

Likely market impact

Eligible shareholders can tender shares at Rs 27 each on proportionate basis. Promoters opting out. May support share price near-term.